TAK1: a potent tumour necrosis factor inhibitor for the treatment of inflammatory diseases

by Juliane Totzke, Scott A. Scarneo, Kelly W. Yang, Timothy A. J. Haystead
Published 2020-09-01

Pharmacological inhibition of TAK1, with the selective inhibitor takinib, alleviates clinical manifestation of arthritis in CIA mice

by Scott A. Scarneo, Liesl S. Eibschutz, Phillip J. Bendele, Kelly W. Yang, Juliane Totzke, Philip Hughes, David A. Fox, Timothy A. J. Haystead
Published 2019-12-01